156 related articles for article (PubMed ID: 17264123)
1. Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity.
Hamard PJ; Boyer-Guittaut M; Camuzeaux B; Dujardin D; Hauss C; Oelgeschläger T; Vigneron M; Kedinger C; Chatton B
Nucleic Acids Res; 2007; 35(4):1134-44. PubMed ID: 17264123
[TBL] [Abstract][Full Text] [Related]
2. p38beta2-mediated phosphorylation and sumoylation of ATF7 are mutually exclusive.
Camuzeaux B; Diring J; Hamard PJ; Oulad-Abdelghani M; Donzeau M; Vigneron M; Kedinger C; Chatton B
J Mol Biol; 2008 Dec; 384(4):980-91. PubMed ID: 18950637
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
[TBL] [Abstract][Full Text] [Related]
4. The RanBP2/RanGAP1*SUMO1/Ubc9 complex: a multisubunit E3 ligase at the intersection of sumoylation and the RanGTPase cycle.
Flotho A; Werner A
Nucleus; 2012; 3(5):429-32. PubMed ID: 22925898
[TBL] [Abstract][Full Text] [Related]
5. A functional interaction between ATF7 and TAF12 that is modulated by TAF4.
Hamard PJ; Dalbies-Tran R; Hauss C; Davidson I; Kedinger C; Chatton B
Oncogene; 2005 May; 24(21):3472-83. PubMed ID: 15735663
[TBL] [Abstract][Full Text] [Related]
6. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
Reverter D; Lima CD
Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
[TBL] [Abstract][Full Text] [Related]
7. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
Werner A; Flotho A; Melchior F
Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
[TBL] [Abstract][Full Text] [Related]
8. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
10. Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex.
Sakin V; Richter SM; Hsiao HH; Urlaub H; Melchior F
J Biol Chem; 2015 Sep; 290(39):23589-602. PubMed ID: 26251516
[TBL] [Abstract][Full Text] [Related]
11. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
Gareau JR; Reverter D; Lima CD
J Biol Chem; 2012 Feb; 287(7):4740-51. PubMed ID: 22194619
[TBL] [Abstract][Full Text] [Related]
12. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
[TBL] [Abstract][Full Text] [Related]
13. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation can regulate the activity of ETS-like transcription factor 4.
Kaikkonen S; Makkonen H; Rytinki M; Palvimo JJ
Biochim Biophys Acta; 2010 Aug; 1799(8):555-60. PubMed ID: 20637912
[TBL] [Abstract][Full Text] [Related]
15. Regulation of IRF2 transcriptional activity by its sumoylation.
Han KJ; Jiang L; Shu HB
Biochem Biophys Res Commun; 2008 Aug; 372(4):772-8. PubMed ID: 18514056
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Wnt signaling by the nuclear pore complex.
Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
[TBL] [Abstract][Full Text] [Related]
17. Functional modulation of parkin through physical interaction with SUMO-1.
Um JW; Chung KC
J Neurosci Res; 2006 Nov; 84(7):1543-54. PubMed ID: 16955485
[TBL] [Abstract][Full Text] [Related]
18. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
19. Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.
Teramachi J; Hiruma Y; Ishizuka S; Ishizuka H; Brown JP; Michou L; Cao H; Galson DL; Subler MA; Zhou H; Dempster DW; Windle JJ; Roodman GD; Kurihara N
J Bone Miner Res; 2013 Jun; 28(6):1489-500. PubMed ID: 23426901
[TBL] [Abstract][Full Text] [Related]
20. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]